In response to the evolving health risk posed by the COVID-19 pandemic, the Office of Controlled Substances (OCS) is taking temporary measures to reduce the likelihood of spreading COVID-19 between consumers and pharmacists when returning products that may contain controlled substances to a pharmacy. More information can be found in the OCS Bulletin.
If you have any questions, please contact Health Canada’s Office of Controlled Substances at hc.compliance-conformite.sc@canada.ca.